Skip to main content

Table 4 Pilot study – outcomes of medicines review

From: Addressing potentially inappropriate prescribing in older patients: development and pilot study of an intervention in primary care (the OPTI-SCRIPT study)

Patient

PIP

Outcome of review

1

PPI

Dose reduction

TCA and CCB

TCA discontinued

2

PPI

Dose reduction

Therapeutic duplication - ACE and ARB

ARB discontinued

3

Long term long acting benzodiazepine

Dose reduction

4

PPI

Dose reduction

5

Bladder antimuscarinics and constipation

Left unaltered

6

NSAID and diuretic

NSAID discontinued

7

NSAID and ACE

NSAID discontinued

8

Long term steroid for maintenance therapy in COPD/Asthma

Switched from steroid to other treatment

  1. Abbreviations: ACEI Angiotensin-converting-enzyme inhibitor, ARB Angiotensin II receptor blockers, CCB Calcium channel blocker, COPD Chronic obstructive pulmonary disease, NSAID Nonsteroidal anti-inflammatory drugs, PPI Proton pump inhibitor, TCA Tricyclic anti-depressant.
  2. Note: The decision on whether to follow the recommended treatment alternatives will be at the discretion of the GP, weighing up the risks and benefits and patient preference.